• Products
  • Applications
  • Resources
  • Support
  • Order

Genovis AB (publ) to Publish Q3 2015 Report Ahead of Schedule

October 23, 2015 | Press Releases | Genovis

The Board of Directors of Genovis AB (publ) has decided to publish Q3 2015 report ahead of schedule.

The Interim Report for January-September, which was to be announced on November 23, 2015, will be published ahead of schedule. The new publication date for the report is November 3, 2015.

Recent Articles

  • Evaluating the Impact of Antibody Fragments on Aggregation using FabALACTICA®
  • Multi-Attribute mAb Variant Characterization with CE-MS and FabRICATOR® Digestion
  • GlyCLICK®-generated ADC Suppresses Tumor Growth in Pancreatic Cancer Models

Categories

  • Applications
  • Bioprocess
  • Conferences
  • Genomics
  • Genovis Team
  • GenovisWebinars
  • Interview
  • New Application Note
  • New Product
  • News
  • Poster Abstracts
  • Press Releases
  • Products
  • References
  • Uncategorized

Tags

ADC bispecific CE-MS Characterization Charge Variants Etanercept F(ab')2 FabALACTICA FabRICATOR FabRICATOR Z Fc-glycosylation FragIT FragIT kit fucosexo genomics GingisKHAN Glycation GlycINATOR GlyCLICK Glycosylation HILIC HILIC-MS IgGZERO Imaging Intact LC-MS launch LC-MS LC/MS mAb mAb Quality Middle-down Middle-up news O-glycans Operator Oxidation product launch rnase rnase inhibitor SEC-MS sequrna SialEXO smartenzymes Subunit transglycit

EMEA & Asia

Genovis AB
Box 4
SE-244 21 Kävlinge
Sweden

+46 46 10 12 30

USA & Canada

Genovis Inc
245 First Street 
Cambridge, MA 02142
USA

(617) 444-8421

Customer Support

FAQ
Contact support
Terms & Conditions
References
Products
Online store

Corporate

About us
Investor relations
Contact IR

Facebook
LinkedIn